Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields
The participants are being treated with Tumor Treating Fields (TTFields) for malignant glioma, and this type of treatment may cause skin-related side effects. This study will test whether using clindamycin and triamcinolone topical lotions can prevent skin-related side effects of TTFields.
Glioblastoma|Recurrent Glioblastoma|Skin Toxicity
DRUG: Clindamycin Phosphate|DRUG: Triamcinolone Acetonide
Number of patients without grade 2 or higher skin toxicity, device-related skin adverse events by investigator assessment., up to 120 days
skin-related quality of life, using the PRO-CTCAE for rash, ulcer, and pruritus., up to 120 days
The participants are being treated with Tumor Treating Fields (TTFields) for malignant glioma, and this type of treatment may cause skin-related side effects. This study will test whether using clindamycin and triamcinolone topical lotions can prevent skin-related side effects of TTFields.